I led the successful AIDD strategic collaboration design with clients, and helped them to achieve:- FIC project: Identified hits within 30 syntheses in a FIC pipeline with no pre-existing clinical drugs- BIC project: Achieved better potency within just 6 syntheses, currently in Phase II clinical trials; Phase II clinical trial data to be presented at the ADA Conference, June 2024Divamics Inc. is a biotechnology company with a core technology of multi-scale molecular dynamics. Using our patented tech of AI-based GARF force field and MovableType algorithm, we have helped 25+ MNCs and biotechs (including 7 listed companies, 2 American biotechs) around the world to most efficiently hunt new PCCs in areas of GPCR, allosteric site, PPI, small molecules, peptide, Protac, and XDCs, etc.I build a commercial team from 0 to 1, developing and iterating the company's productstrategy, pricing strategy, expansion strategy, incentive plan, and assessment plan combining OKR and KPI based on strategic goals.

I was responsible for the data analysis training business line of the company, especially the AI+Finance course products, developing and implementing online and offline promotional plans, developing brand, pricing, and marketing strategies, and obtaining 13 financial institution clients within one year, with a total of 30000 C-end trainees

I was responsible for the construction and implementation of the AI-based retail databank project, coordinating the operation data of 6 departments to complete report automation, saving 30000+ hours of repetitive labor hours in peak season, and assisting management in analyzing operation data.I led team to design the "New Generation Private Customized Investment Manager" product and win the 2022 Most Valuable Award.